PDL BioPharma Sells Minnesota Facility for $240 Million

PDL BioPharma Inc. sold its Brooklyn Park, Minn., antibody manufacturing facility to Genmab A/S of Denmark, the latest asset-shedding move by the company.
East Bay Business Times